Trial Condition(s):
Contraception
Drug Utilzation Study in Croatia
Bayer Identifier:
14555
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study Completed
Trial Purpose
The primary objective of the study was to characterize the prescribing behaviors for Yasmin® and other oral contraceptives (OCs) in Croatia.
Inclusion Criteria
: Women prescribed oral contraceptives (OC) between February 16th, 2009 and March 15th, 2009 in Croatia.
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
N/A
Trial Dates
Phase
N/A
Could I receive a placebo?
No
Products
Yasmin (EE30/DRSP, BAY86-5131)
Accepts Healthy Volunteers
N/A
Where to Participate
Locations
Status
| Locations | Status |
|---|
Trial Design
Drug Utilization Study on the Prescribing Indications for Yasmin® and Other OCs in Croatia
Trial Type:
Observational
Intervention Type:
N/A
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
2
Primary Outcome
- Prescribing indications for Yasmin® and other OCs in CroatiaTimeframe:
- Off-label use of Yasmin® and other OCs in CroatiaTimeframe:
- Current market share of Yasmin® in CroatiaTimeframe:
Additional Information
Copyright © Bayer
Powered by
